colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The pathological diagnosis was in line with the diagnostic criteria of colorectal cancer and the syndrome differentiation of TCM was spleen deficiency and stasis; (2) Patients with pathological stage III who have undergone radical surgery; (3) ECOG score =2 points aged between 18-75 years old; (4) The expected survival time is more than 6 months; (5) Sign informed consent. Volunteer to take the test. The process of obtaining informed consent shall comply with GCP regulations.
Exclusion criteria
Exclusion criteria: (1) Patients with metastatic colorectal cancer; (2) Local recurrence or distant metastasis has been confirmed by histopathology or imaging examination; (3) pregnant and lactating women; (4) severe primary cardiovascular disease liver disease kidney disease hematological disease; (5) have serious primary heart liver lung kidney blood or serious diseases affecting their survival; (6) Persons with disabilities defined by law (blind deaf mute mentally handicapped mentally handicapped physically handicapped); (7) Suspected or have a history of alcohol and drug abuse; (8) Other diseases that reduce the possibility of enrollment or complicate enrollment such as frequent changes in the working environment are likely to cause loss of follow-up according to the judgment of the investigator; (9) allergies such as allergies to two or more drugs or food; Or known allergy to the ingredients of the drug; (10) Patients who are participating in clinical studies of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cytokine detection;disease-free survival;Cell immune function test;1-year and 2-year progression-free survival rates; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall chemotherapy completion rate;Tumor markers;Quality of life score;TCM syndrome scores; | — |
Countries
China
Contacts
Jiangsu Province Hospital of Chinese Medicine